End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,400 KRW | +2.01% | +4.29% | -14.49% |
03-14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
Chart calendar JW Pharmaceutical Corporation
Past events on JW Pharmaceutical Corporation
2024-03-31 | Q4 2023 Earnings Release (Projected) |
2023-05-14 | Q1 2023 Earnings Release |
2023-03-20 | Q4 2022 Earnings Release |
2022-11-13 | Q3 2022 Earnings Release |
2022-08-15 | Interim 2022 Earnings Release |
2022-05-15 | Q1 2022 Earnings Release |
2021-08-16 | Interim 2021 Earnings Release |
2021-05-16 | Q1 2021 Earnings Release |
2021-03-17 | FY 2020 Earnings Release |
2020-03-29 | FY 2019 Earnings Release |
2019-11-13 | Q3 2019 Earnings Release |
2019-05-14 | Q1 2019 Earnings Release |
2018-08-13 | Interim 2018 Earnings Release |
2016-06-02 | Sachs Associates Immuno-Oncology BD&L and Investment Forum |
Past dividends on JW Pharmaceutical Corporation
2023-12-26 | Annual 400 KRW |
2022-12-27 | Annual 375 KRW |
2021-12-28 | Annual 325 KRW |
2020-12-28 | Annual 325 KRW |
2019-12-26 | Annual 325 KRW |
2018-12-26 | Annual 325 KRW |
2017-12-26 | Annual 275 KRW |
2016-12-27 | Annual 142.857 KRW |
2015-12-28 | 119.0475 KRW |
2014-12-28 | Annual 125 KRW |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 0,00 | 684 672 1.84% | 750 750 -0.01% | 827 |
EBITDA Billions KRW | Released Forecast Spread | 0,00 | 79,8 69,0 15.65% | 123 115 6.94% | 124 |
EBIT Billions KRW | Released Forecast Spread | 0,00 | 64,4 55,0 17.17% | 99,6 95,5 4.23% | 106 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | 46,4 45,0 3.14% | 51,6 56,0 -7.84% | 95,0 |
Net income Billions KRW | Released Forecast Spread | -0,92 | 33,5 34,0 -1.32% | 34,8 44,5 -21.7% | 73,5 |
EPS KRW | Released Forecast Spread | -40,0 | 1 305 1 512 -13.72% | 1 529 1 851 -17.4% | 3 056 |
Announcement Date | 21/03/22 | 08/02/23 | 05/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 156 157 -0.23% | 165 164 0.37% | 170 | 193 187 3.4% | 173 181 -4.31% | 186 185 0.37% | 184 193 -4.76% | 205 209 -1.67% | 186 | 205 | 217 | 218 |
EBIT Billions KRW | Released Forecast Spread | 13,3 15,4 -13.49% | 9,40 16,1 -41.6% | 11,6 | 30,2 17,5 72.36% | 20,3 11,8 72.24% | 20,6 18,7 10.22% | 26,1 19,6 32.97% | 33,3 27,4 21.67% | 24,0 | 25,1 | 26,6 | 30,7 |
Net income Billions KRW | Released Forecast Spread | 13,1 13,4 -2.42% | -17,9 14,5 -223.52% | 25,0 29,4 -15.09% | 19,5 | 19,2 | 20,1 | 14,1 | |||||
Announcement Date | 16/05/22 | 16/08/22 | 15/11/22 | 08/02/23 | 15/05/23 | 14/08/23 | 14/11/23 | 05/02/24 | - | - | - | - |
Past sector events for JW Pharmaceutical Corporation
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A001060 Stock
- Calendar JW Pharmaceutical Corporation